Your browser doesn't support javascript.
New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm.
Kanthi, Yogendra; Knight, Jason S; Zuo, Yu; Pinsky, David J.
  • Kanthi Y; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Knight JS; Section of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.
  • Zuo Y; Division of Rheumatology, Department of Internal Medicine and.
  • Pinsky DJ; Division of Rheumatology, Department of Internal Medicine and.
JCI Insight ; 5(14)2020 07 23.
Article in English | MEDLINE | ID: covidwho-768184

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thrombosis / Coronavirus Infections / Dipyridamole / Purinergic Agents / Cytokine Release Syndrome Type of study: Prognostic study Limits: Humans Language: English Year: 2020 Document Type: Article Affiliation country: JCI.INSIGHT.140971

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thrombosis / Coronavirus Infections / Dipyridamole / Purinergic Agents / Cytokine Release Syndrome Type of study: Prognostic study Limits: Humans Language: English Year: 2020 Document Type: Article Affiliation country: JCI.INSIGHT.140971